Ceschan Nazareth Eliana, Bucalá Verónica, Ramírez-Rigo María Verónica, Smyth Hugh David Charles
Planta Piloto de Ingeniería Química (PLAPIQUI), CONICET - Universidad Nacional del Sur (UNS), Camino La Carrindanga km 7, 8000 Bahía Blanca, Argentina; Departamento de Biología, Bioquímica y Farmacia, UNS, San Juan 670, 8000 Bahía Blanca, Argentina.
Planta Piloto de Ingeniería Química (PLAPIQUI), CONICET - Universidad Nacional del Sur (UNS), Camino La Carrindanga km 7, 8000 Bahía Blanca, Argentina; Departamento de Ingeniería Química, UNS, Avenida Alem 1253, 8000 Bahía Blanca, Argentina.
Eur J Pharm Biopharm. 2016 Dec;109:72-80. doi: 10.1016/j.ejpb.2016.09.020. Epub 2016 Sep 30.
The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference have often lead researchers to focus on dry powder inhaler delivery systems. Atenolol is an antihypertensive drug with low oral bioavailability and gastrointestinal side effects. Because atenolol possesses adequate permeation across human epithelial membranes, it has been proposed as a good candidate for inhalatory administration. In a previous work, atenolol was combined with alginic acid (AA) and microparticles were developed using spray-drying (SD) technology. Different AA/atenolol ratios, total feed solid content and operative variables were previously explored. In order to improve particle quality for inhalatory administration and the SD yield, in this work the AA acid groups not neutralized by atenolol were kept either free or neutralized to pH∼7 and two different SD cyclones were used. Particle morphology, flow properties, moisture uptake and in vitro aerosolization behavior at different pressure drops were studied. When the AA acid groups were neutralized, particle size decreased as a consequence of the lower feed viscosity. The SD yield and in vitro particle deposition significantly increased when a high performance cyclone was employed, and even when lactose carrier particles were not used. Although the in vitro particle deposition decreased when the storage relative humidity increased, the developed SD powders showed adequate characteristics to be administered by inhalatory route up to storage relative humidities of about 60%.
吸入途径已成为一种有趣的非侵入性给药替代方法。这既可以进行肺部(局部)治疗,也可以通过肺泡吸收进行全身治疗。在稳定性、剂量和患者偏好方面的进一步优势常常使研究人员将重点放在干粉吸入器给药系统上。阿替洛尔是一种口服生物利用度低且有胃肠道副作用的抗高血压药物。由于阿替洛尔在人上皮膜上具有足够的渗透性,因此已被提议作为吸入给药的良好候选药物。在先前的一项工作中,阿替洛尔与海藻酸(AA)结合,并使用喷雾干燥(SD)技术制备了微粒。之前已经探索了不同的AA/阿替洛尔比例、总进料固体含量和操作变量。为了提高吸入给药的颗粒质量和SD产率,在这项工作中,未被阿替洛尔中和的AA酸基团保持游离状态或中和至pH约为7,并使用了两种不同的SD旋风分离器。研究了颗粒形态、流动特性、吸湿情况以及在不同压降下的体外雾化行为。当AA酸基团被中和时,由于进料粘度较低,颗粒尺寸减小。当使用高性能旋风分离器时,即使不使用乳糖载体颗粒,SD产率和体外颗粒沉积也显著增加。尽管当储存相对湿度增加时体外颗粒沉积减少,但所制备的SD粉末在储存相对湿度高达约60%时仍具有足够的特性可通过吸入途径给药。